Escudier B, Tannir NM, McDermott DF, et al. CheckMate 214: Efficacy and safety of nivolumab plus ipilimumab vs sunitinib for treatment-naïeve advanced or metastatic renal cell carcinoma, including IMDC risk and PD-L1 expression subgroups. ESMO 2017 Congress; abstract LBA5.
Betere overleving radicale prostatectomie plus radiotherapie bij mannen met gevorderd prostaatcarcinoom
nov 2018 | Radiotherapie, Uro-oncologie